Evercore Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Evercore Wealth Management, LLC

$6.66 Billion
Q3 2024

A detailed history of Evercore Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Evercore Wealth Management, LLC holds 1,305 shares of REGN stock, worth $915,914. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,305

Previous 1,305 -0.0%

Holding current value

$915,914

Previous $1.37 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $138,111 - $151,982	-153 Reduced 10.49%	1,305 $1.26 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $775 - $881	-1 Reduced 0.07%	1,458 $1.28 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $32,545 - $39,685	-47 Reduced 3.12%	1,459 $1.2 Million
Q2 2023 Aug 04, 2023	SELL	$700.03 - $830.35 $74,203 - $88,017	-106 Reduced 6.58%	1,506 $1.08 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $19,053 - $23,155	-28 Reduced 1.71%	1,612 $1.32 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $122,118 - $132,585	173 Added 11.79%	1,640 $1.18 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $111,924 - $141,242	195 Added 15.33%	1,467 $1.01 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $3,290 - $4,433	-6 Reduced 0.47%	1,272 $752,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $771,275 - $905,165	-1,296 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $24,456 - $30,193	-45 Reduced 3.36%	1,296 $819,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $86,104 - $102,144	-150 Reduced 10.06%	1,341 $812,000
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $1,418 - $1,675	-3 Reduced 0.2%	1,491 $833,000
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $64,775 - $79,489	145 Added 10.75%	1,494 $707,000
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $30,132 - $38,302	63 Added 4.9%	1,349 $651,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $1,634 - $1,974	-3 Reduced 0.23%	1,286 $719,000
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $4,439 - $5,795	-9 Reduced 0.69%	1,289 $804,000
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $45,384 - $66,748	135 Added 11.61%	1,298 $634,000
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $55,512 - $64,633	-203 Reduced 14.86%	1,163 $322,000
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $56,324 - $77,986	-188 Reduced 12.1%	1,366 $427,000
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $6,325 - $7,472	17 Added 1.11%	1,554 $638,000
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $2,350 - $2,821	-7 Reduced 0.45%	1,537 $574,000
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $26,686 - $31,046	-76 Reduced 4.69%	1,544 $624,000
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $5,692 - $6,899	-20 Reduced 1.22%	1,620 $559,000
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $43,898 - $54,735	-139 Reduced 7.81%	1,640 $565,000
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $767,425 - $896,616	1,779	1,779 $795,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.

Account

Evercore Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History